(intermittent claudication)
11,461 results
  • Cognitive Impairment and Cerebral Haemodynamics in Individuals with Symptomatic Peripheral Artery Disease. [Journal Article]
    Am J Physiol Heart Circ Physiol. 2026 Sep 29. [Online ahead of print]Cheshire BL, Sensier YJ, … Houghton JSMAJ
  • Peripheral artery disease (PAD) is highly prevalent in older adults. PAD is associated with cognitive impairment; however the underlying mechanisms are unclear. The brain's metabolic needs rapidly change in response to neuronal activity requiring adjustment of regional cerebral blood flow, termed neurovascular coupling (NVC). The microvascular endothelium contributes to NVC responses. Patients wi…
  • [Popliteal artery entrapment syndrome]. [Journal Article]
    Chirurgie (Heidelb). 2026 Sep 16. [Online ahead of print]Behrens A, Dorweiler BC
  • Popliteal artery entrapment syndrome (PAES) is a cause of exertional calf pain, predominantly affecting young athletic patients without pre-existing vascular disease. Although the condition is generally rare, the number of undetected asymptomatic cases is thought to be substantial. In up to two thirds of cases the PAES is bilateral. Pathophysiologically, it results from external compression of th…
  • CHA2DS2-VASc Score for Risk Stratification After Endovascular Therapy in Patients With Symptomatic Peripheral Artery Disease. [Journal Article]
    J Endovasc Ther. 2026 Sep 15; :15266028261484801. [Online ahead of print]Shima Y, Karashima E, … Abe MJE
  • CONCLUSIONS: In patients undergoing EVT for symptomatic PAD, a higher CHA2DS2-VASc score was independently associated with increased 3-year mortality. This widely available score may serve as a simple adjunctive tool for initial risk stratification after EVT and may complement established PAD-specific prognostic assessments.Clinical ImpactPatients undergoing endovascular therapy (EVT) for symptomatic peripheral artery disease remain at substantial risk of long-term mortality. In this multicenter study, the CHA2DS2-VASc score was independently associated with 3-year mortality across a broad spectrum of symptomatic PAD, including intermittent claudication and chronic limb-threatening ischemia. Although PAD- and CLTI-specific prognostic models provide superior discrimination, the CHA2DS2-VASc score is simple, universally recognized, and immediately available without disease-specific assessments. It may serve as an adjunctive tool for initial risk stratification and complement established prognostic models in routine clinical practice.
  • Cholesterol embolization syndrome: A case report and literature review. [Case Reports]
    J Vasc Surg Cases Innov Tech. 2026 Dec; 12(6):102422.Zhang XJV
  • Cholesterol embolization syndrome is a clinical condition caused by cholesterol crystals dislodged from atherosclerotic plaques, leading to distal arterial occlusion and subsequent organ ischemia. We present a case of a 61-year-old male who developed blue toe syndrome, reticular livedo, and gastrointestinal bleeding 1 week after aortic interventional therapy for intermittent claudication. The pat…
  • Anaemia prevalence, characterisation, and clinical impact in intermittent claudication. [Journal Article]
    Ann Vasc Surg. 2026 Sep 04. [Online ahead of print]Hong JS, Loy G, … El-Sayed TAV
  • CONCLUSIONS: Anaemia affects approximately one in five patients with intermittent claudication and represents a significant treatment gap, with 77.8% receiving no therapy, despite anaemia was associated with higher MACE and mortality risk. A prospective randomised controlled trial evaluating the efficacy of anaemia treatment strategies in this cohort may help to improve understanding and guide clinical management.